LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Sirolimus | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3311 | 4405 | 0.7516 | 0.7112 |
MDA-MB-231 | Sirolimus | 10 | uM | LJP6 | 72 | hr | 1235 | 3274 | 4405 | 0.7430 | 0.7002 |
MDA-MB-231 | ZSTK474 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3680 | 4405 | 0.8361 | 0.8142 |
MDA-MB-231 | ZSTK474 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3522 | 4405 | 0.8000 | 0.7710 |
MDA-MB-231 | ZSTK474 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3300 | 4405 | 0.7503 | 0.7101 |
MDA-MB-231 | ZSTK474 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2846 | 4405 | 0.6472 | 0.5774 |
MDA-MB-231 | ZSTK474 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2374 | 4405 | 0.5395 | 0.4279 |
MDA-MB-231 | ZSTK474 | 10 | uM | LJP6 | 72 | hr | 1235 | 1901 | 4405 | 0.4313 | 0.2620 |
MDA-MB-231 | BX-912 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4297 | 4660 | 0.9201 | 0.9126 |
MDA-MB-231 | BX-912 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3850 | 4660 | 0.8257 | 0.8085 |
MDA-MB-231 | BX-912 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2132 | 4660 | 0.4572 | 0.3274 |
MDA-MB-231 | BX-912 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1614 | 4660 | 0.3456 | 0.1468 |
MDA-MB-231 | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1343 | 4660 | 0.2874 | 0.0410 |
MDA-MB-231 | BX-912 | 10 | uM | LJP5 | 72 | hr | 1235 | 663 | 4660 | 0.1417 | -0.2808 |
MDA-MB-231 | Selumetinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3888 | 4405 | 0.8832 | 0.8691 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3641 | 4405 | 0.8273 | 0.8039 |
MDA-MB-231 | Selumetinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3086 | 4405 | 0.7006 | 0.6469 |
MDA-MB-231 | Selumetinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2705 | 4405 | 0.6153 | 0.5342 |
MDA-MB-231 | Selumetinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2332 | 4405 | 0.5296 | 0.4138 |
MDA-MB-231 | Selumetinib | 10 | uM | LJP6 | 72 | hr | 1235 | 1577 | 4405 | 0.3581 | 0.1418 |
MDA-MB-231 | MK2206 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 4100 | 4405 | 0.9310 | 0.9237 |
MDA-MB-231 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3998 | 4405 | 0.9080 | 0.8976 |
MDA-MB-231 | MK2206 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3881 | 4405 | 0.8809 | 0.8661 |
MDA-MB-231 | MK2206 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3694 | 4405 | 0.8395 | 0.8182 |
MDA-MB-231 | MK2206 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 3454 | 4405 | 0.7849 | 0.7523 |